Since CD26 is a specific marker for CML LSC and MPN patients may harbor small BCR::ABL1+ subclones, we examined neoplastic cells for expression of BCR::ABL1. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.